causal

Benchling Should Not Be Judged as Veeva for R&D

When Benchling first appeared, the classic lens was to call it Veeva for R&D, but applying a Veeva template would have suffocated its potential, since its R&D focus and academic spinout users require a different motion than commercial pharma sales.

causalpending

Speaker

Miles

Evidence Quote

“Benchling is on the R&D side, which is very different to being on the commercial side.”

Source

Miles Grimshaw - The DNA of Software Companies - [Invest Like the Best, EP.312]— Invest Like the Best
Created: 11/20/2026, 9:00:23 AM

Your notes

Loading notes...